6
Total investments
0
Early stage
1
Mid stage
0
Late stage
15y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Feb 2026
Immorta Bio, Inc, a regenerative medicine company dedicated to providing patient specific therapeutic solutions for Treating Diseases of Aging and Treating Aging as Disease™. We are developing personalized stem cell technologies that provide the greatest promise in the fight against diseases of aging.
Experience · 7 entries
All (7)
Investments (6)
Board (6)
2026
Board Member
Feb 2026
Immorta Bio, Inc, a regenerative medicine company dedicated to providing patient specific therapeutic solutions for Treating Diseases of Aging and Treating Aging as Disease™. We are developing personalized stem cell technologies that provide the greatest promise in the fight against diseases of aging.
2025
Board Member
Sep 2025
A Community-Based Public Health Initiative Dedicated to Preventing Genetic Diseases and Promoting Healthy Families.
2014
P
Philadelphia Eagles Charitable Foundation
Board Member
Aug 2014
2013
P
Philadelphia Sports Congress
Executive Board Member
Jun 2013
2011
Eastern PA Chapter Board Member
2011
As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures.
We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition.
For more information, visit www.BreakthroughT1D.org
Show all 7 entries ↓
Investment activity
2011–2026 · 6 investments
Recent (last 2 years)Earlier